Is the group of older sickle cell disease patients from Trinidad and Tobago different?
Rafael
R
Losada
Idania
I
Bravo
Kavi
K
Capildeo
Kenneth
K
Charles
D000328:Adult; D000368:Aged; D000375:Aging / Q000473:pathology*; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000473:pathology* / Q000503:physiopathology; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D005260:Female; D016523:Foot Ulcer / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D014300:Trinidad and Tobago
D000986:Antisickling Agents; D006918:Hydroxyurea